Survival nomogram for stage IB non-small-cell lung cancer patients, based on the SEER database and an external validation cohort

Z Zuo, G Zhang, P Song, J Yang, S Li, Z Zhong… - Annals of surgical …, 2021 - Springer
Objective This study aimed to construct a nomogram to effectively predict the overall survival
(OS) of patients with stage IB non-small-cell lung cancer (NSCLC). Methods In total, 5513 …

Lung cancer management in low and middle-income countries

S Jiwnani, P Penumadu, A Ashok… - Thoracic Surgery …, 2022 - thoracic.theclinics.com
Low-and middle-income countries (LMICs) 1 have witnessed a rise in mortality due to
noncommunicable diseases in the last 2 decades. 2 Although cancer accounted for 9.3 …

[HTML][HTML] Impact of lymphadenectomy extent on immunotherapy efficacy in post-resectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort …

H Deng, J Zhou, H Chen, X Cai, R Zhong… - … Journal of Surgery, 2023 - journals.lww.com
Background: Lymph node (LN) dissection is a common procedure for non-small cell lung
cancer (NSCLC) to ascertain disease severity and treatment options. However, murine …

Assessment of updated commission on cancer guidelines for intraoperative lymph node sampling in early stage NSCLC

BT Heiden, DB Eaton Jr, SH Chang, Y Yan… - Journal of Thoracic …, 2022 - Elsevier
Abstract Introduction The American College of Surgeons Commission on Cancer recently
updated its sampling recommendations for early stage NSCLC from at least 10 lymph nodes …

[HTML][HTML] Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study

Y Yu, P Zhang, R Yao, J Wang, P Wang… - Translational Lung …, 2020 - ncbi.nlm.nih.gov
Background Log odds of positive lymph nodes (LODDS) is a novel and promising ratio-
based lymph node (LN) staging system in many malignancies. This study aimed to evaluate …

The IASLC proposed grading system accurately predicts prognosis and mediastinal nodal metastasis in patients with clinical stage I lung adenocarcinoma

L Xu, H Su, L Hou, F Wang, H Xie, Y She… - The American Journal …, 2022 - journals.lww.com
Abstract The International Association for the Study of Lung Cancer (IASLC) recently
proposed a new grading system for lung adenocarcinoma (LUAD). We aimed to validate the …

Risk factors for occult lymph node metastasis in peripheral non-small cell lung cancer with invasive component size 3 cm or less

Y Moon, SY Choi, JK Park, KY Lee - World Journal of Surgery, 2020 - Springer
Background In the seventh edition TNM staging system for lung cancer, a high maximum
standardized uptake value (SUVmax) on positron emission tomography was regarded as a …

Effect of adjuvant chemotherapy on survival of patients with 8th edition stage IB non-small cell lung cancer

Y Xu, B Wan, S Zhu, T Zhang, J Xie, H Liu… - Frontiers in …, 2022 - frontiersin.org
Background The efficacy of adjuvant chemotherapy in patients with 8th edition stage IB
(tumor size≤ 4 cm) non-small cell lung cancer (NSCLC) remains unclear. Methods We …

Lymph node upstaging for robotic, thoracoscopic, and open lobectomy for stage T2-3N0 lung cancer

RE Merritt, M Abdel-Rasoul, DM D'Souza… - The Annals of Thoracic …, 2023 - Elsevier
Background There may be equivalent efficacy of the lymph node evaluation for minimally
invasive lobectomy compared with open lobectomy for stage I non-small cell lung cancer …

Prognostic impact of examined mediastinal lymph node count in clinical N0 non-small cell lung cancer

A Kamigaichi, K Aokage, S Katsumata… - European Journal of …, 2022 - academic.oup.com
OBJECTIVES The number of examined mediastinal lymph nodes (mLNs) could represent
the quality of mediastinal lymphadenectomy for non-small cell lung cancer (NSCLC). This …